|
CD164 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.26669785771583E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.54970036803093E-10 |
| Normal-vs-Stage2 |
1.9390199999969E-05 |
| Normal-vs-Stage3 |
7.095500E-03 |
| Normal-vs-Stage4 |
6.075400E-03 |
| Stage1-vs-Stage2 |
3.314200E-01 |
| Stage1-vs-Stage3 |
9.082800E-03 |
| Stage1-vs-Stage4 |
2.095200E-01 |
| Stage2-vs-Stage3 |
1.409190E-01 |
| Stage2-vs-Stage4 |
3.869400E-01 |
| Stage3-vs-Stage4 |
6.614400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.70412597763925E-12 |
| Normal-vs-AfricanAmerican |
1.52909999995288E-06 |
| Normal-vs-Asian |
2.230800E-01 |
| Caucasian-vs-AfricanAmerican |
2.418200E-01 |
| Caucasian-vs-Asian |
7.777800E-01 |
| AfricanAmerican-vs-Asian |
9.382800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.27784457962343E-12 |
| Normal-vs-Female |
1.77359999997684E-06 |
| Male-vs-Female |
1.937430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.95650000003977E-06 |
| Normal-vs-Extreme_Weight |
8.33810798184231E-12 |
| Normal-vs-Obese |
1.06519999487631E-08 |
| Normal-vs-Extreme_Obese |
2.299900E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.762420E-01 |
| Normal_Weight-vs-Obese |
9.770000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.148800E-01 |
| Extreme_Weight-vs-Obese |
8.777700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.711800E-02 |
| Obese-vs-Extreme_Obese |
2.027400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.940100E-03 |
| Normal-vs-Age(41-60Yrs) |
3.23600002349878E-09 |
| Normal-vs-Age(61-80Yrs) |
2.44779752023305E-11 |
| Normal-vs-Age(81-100Yrs) |
3.555100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.585000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.700240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.524000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.880000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.150800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.804200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.76323408598955E-12 |
| Normal-VS-Type2 PRCC |
3.83959999999961E-05 |
| Normal-VS-KIRP CIMP |
1.019820E-02 |
| Normal-VS-Unclassified PRCC |
1.11760000143235E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.194390E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.921630E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.009800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.612800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.401700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.156400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.58090000001998E-06 |
| Normal-vs-N1 |
3.622000E-03 |
| Normal-vs-N2 |
1.44690037728878E-10 |
| N0-vs-N1 |
1.589630E-01 |
| N0-vs-N2 |
3.979400E-03 |
| N1-vs-N2 |
3.617400E-04 |
|
|
